Genefron Ltd. is active in the field of genomic based personal medicine. Powered by AI and Gene expression signatures, we predict the appropriate treatment for patients with auto-immune diseases and the prognosis of disease in viral infections.
Our promise, forever to be kept, is to focus on the individual patient needs, reduce patient suffer and direct the ultimate treatment for the fastest recovery possible.
Due to our novel technology we received grants from the Israeli Innovation Authority as well as Seal of Excellence certification from the European Commission as the institution managing Horizon 2020.
